Luminex's Q3 Revenues Increase 16 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market yesterday that its third-quarter revenues increased 16 percent, though it reported a drop in system sales.

The Austin, Texas-based manufacturer of multiplex instruments and diagnostic assays reported total revenues of $33.9 million for the three-month period ended Sept. 30, compared to revenues of $29.1 million for the third quarter of 2009. The results fell short of Wall Street's consensus estimate of $35.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.